Safety and quality of life with maintenance olaparib plus bevacizumab in older patients with ovarian cancer: subgroup analysis of PAOLA‑1/ENGOT-ov25

In PAOLA-1/ENGOT-ov25, the addition of olaparib to bevacizumab maintenance improved overall survival in patients with newly diagnosed advanced ovarian cancer. We describe the safety profile and quality of life (QoL) of this combination in older patients in PAOLA-1. Safety (CTCAE v4.03) and QoL (EORT...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2024-12
Hauptverfasser:	Montégut, Coline, Falandry, Claire, Cinieri, Saverio, Cropet, Claire, Montane, Laure, Rousseau, Frédérique, Joly, Florence, Moubarak, Malak, Mosconi, Anna M, Guerra-Alía, Eva M, Schauer, Christian, Fujiwara, Hiroyuki, Vergote, Ignace, Parma, Gabriella, Lindahl, Gabriel, Anota, Amélie, Canzler, Ulrich, Marmé, Frederik, Pujade-Lauraine, Eric, Ray-Coquard, Isabelle, Sabatier, Renaud
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In PAOLA-1/ENGOT-ov25, the addition of olaparib to bevacizumab maintenance improved overall survival in patients with newly diagnosed advanced ovarian cancer. We describe the safety profile and quality of life (QoL) of this combination in older patients in PAOLA-1. Safety (CTCAE v4.03) and QoL (EORTC QoL Questionnaires Core 30 and Ovarian 28) data were collected. We compared safety by age (≥70 vs
ISSN:	1083-7159 1549-490X 1549-490X
DOI:	10.1093/oncolo/oyae322